Religare Enterprises Ltd
RELIGAREReligare Enterprises Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved +1.4% in a year while annual EPS moved −31.6% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (11 weeks in) while the P/BV sits at the 63rd percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −687.5% year on year, with the the net margin at −2.0%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Religare Enterprises Ltd trades at ₹257, in a confirmed uptrend and 11 weeks into that stage. That is +6.1% against its own 200-day average. It sits at 70% of a 52-week range of ₹208 to ₹278. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is in a confirmed uptrend — week 11 of stage 2, confirmed. At ₹257 it trades +6.1% versus its 200-day average and sits at 70% of its 52-week range (₹208–₹278).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved −10% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-09-04) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Religare Enterprises Ltd trades at 2.9× P/BV, mid-range by its own standards (63rd percentile). Its long-run median P/BV is 1.5×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 2.9× is mid-range by its own standards (63rd percentile), against a long-run median of 1.5× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 3% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved +1.4% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 10y, of the −0.5%/yr price move, ~−8.2%/yr came from book-value growth and ~+7.7 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 41% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Religare Enterprises Ltd reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −89.1% latest against −40.2% at its 12-quarter best). The read is built from 8 quarters across 3 curves, on partial evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +14.4% | +21.8% | +27.5% | +5.6% |
| Profit | −60.1% | −71.5% | — | +1.8% |
| EPS | −31.6% | −70.0% | — | — |
| Share price | +1.4% | +3.1% | +10.8% | −0.5% |
4-Factor Sector Score
41.2/100 — rank 6 of 8 in Finance - Insurance · 55% evidence confidence
Religare Enterprises Ltd scores 41.2 out of 100 against the 8 companies it is compared with in Finance - Insurance, ranking 6. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 15.4 + 8.8 + 5.2 + 11.8 = 41.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
Religare Enterprises Ltd reported ₹2,353 Cr of income in the Jun 26 quarter, +26.4% year on year. That is the 11th straight quarter of year-on-year growth. Over 10 years it has compounded at 5.6% a year. The last full year, FY26, came in at ₹8,462 Cr. The last four reported quarters add to ₹8,953 Cr.
FY26 revenue came in at ₹8,462 Cr (+14.4% on the year), capping 10 years at 5.6% compound. The latest quarter (Jun 26) printed ₹2,353 Cr, +26.4% year on year — the 11th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +19.2% growth against the decade's 5.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +19.0% over the last 4 quarters against +15.9%/yr over the last 8 — accelerating; TTM profit −89.1% vs −74.7%/yr — rolling over.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
Religare Enterprises Ltd's net margin is −2.0% in the Jun 26 quarter, −2.4 percentage points against the same quarter a year ago. Across 13 fiscal years the net margin has ranged −63.3% to 67.7%. The current quarter sits inside that band.
The latest quarter's net margin is −2.0%, −2.4 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged −63.3%–67.7%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Religare Enterprises Ltd posted a net loss of ₹47.0 Cr in the Jun 26 quarter. Full-year FY26 profit was ₹73.0 Cr. The 10-year compound rate is 1.8%. That loss is 2.0% of the quarter's revenue. The same quarter a year earlier earned ₹8.0 Cr. 3 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹−47.0 Cr, −687.5% year on year. On the full year, FY26 printed ₹73.0 Cr (−60.1%), and the 10-year compound rate is 1.8%.
🚨 Why profit moved: revenue contributed +26.4% and the margin −2.4 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −252.4% vs revenue +19.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Religare Enterprises Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Religare Enterprises Ltd's revenue grew +14.4% in FY26 to ₹8,462 Cr, so the book is growing. The latest quarter ran +26.4% year on year. The net margin on that income is −2.0%, −2.4 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY26 revenue was ₹8,462 Cr, +14.4% on the year, and the latest quarter ran +26.4% year on year. The net margin on that revenue is −2.0% this quarter (−2.4 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers usually rate a lender: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys.
A clean annual return-on-equity ladder is not held for Religare Enterprises Ltd. For an insurer especially the standard bank ratios are not the right lens, so this page does not force them onto the filings rather than estimating a series it cannot support. The revenue, margin and ownership sections above and below are the reads this page stands behind.
We do not hold a clean annual return-on-equity series for Religare Enterprises Ltd — for an insurer especially, the standard bank ratios are not the right lens, so this page does not force them. The revenue, margin and ownership sections above and below are the reads we stand behind.
The quarterly return-on-equity and return-on-assets curves, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 41% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 30.6 points of Religare Enterprises Ltd over 8 quarters, the biggest move on the register. That takes promoters to 30.6% of the company. Domestic institutions moved −1.7 points over the same window, to 9.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +30.6 points over 8 quarters to 30.6%; Domestic institutions: −1.7 points over 8 quarters to 9.3%; Foreign institutions: +1.2 points over 8 quarters to 9.6%.
Why the register moved: promoters drove it (+30.6 points), absorbed on the other side by domestic institutions (−1.7 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Religare Enterprises Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Life Insurance Corporation of IndiaLICI | 72.1/100Favorable setup67% evidence | TURNING | 22.7/35 Income 10.1% · PAT 23.3% 52% evidence | 16.5/25 ROA — · ROE 37.8% · GNPA — 34% evidence | 20.0/20 P/BV 2.89× · P/BV÷ROE 0.08 100% evidence | 12.9/20 RS sector 1.9% · RS bench -3% · 1Y -7.9%2 of 12 weeks ahead 100% evidence |
| Exact sum: 22.7 + 16.5 + 20 + 12.9 = 72.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2ICICI Prudential Life Insurance Company LtdICICIPRULI | 45.9/100Mixed-negative evidence78% evidence | TURNING | 17.3/35 Income -10.5% · PAT 35.7% 75% evidence | 11.3/25 ROA 0.3% · ROE 12.6% · GNPA — 72% evidence | 11.3/20 P/BV 5.02× · P/BV÷ROE 0.4 100% evidence | 6.0/20 RS sector -9% · RS bench -16.3% · 1Y -21%0 of 11 weeks ahead 70% evidence |
| Exact sum: 17.3 + 11.3 + 11.3 + 6 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Canara HSBC Life Insurance Company LtdCANHLIFE | 43.3/100Mixed-negative evidence62% evidence | BREAKING OUT | 24.0/35 Income 9.1% · PAT 9.1% 86% evidence | 5.6/25 ROA 0.2% · ROE 8.1% · GNPA — 72% evidence | 3.7/20 P/BV 8.84× · P/BV÷ROE 1.09 70% evidence | 10.0/20 RS sector — · RS bench — · 1Y —5 of 12 weeks ahead 0% evidence |
| Exact sum: 24 + 5.6 + 3.7 + 10 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Go Digit General Insurance LtdGODIGIT | 43.0/100Mixed-negative evidence82% evidence | BASING | 18.4/35 Income 7.3% · PAT 6.5% 86% evidence | 17.3/25 ROA 2.2% · ROE 12.2% · GNPA — 72% evidence | 7.3/20 P/BV 5.08× · P/BV÷ROE 0.42 70% evidence | 0.0/20 RS sector -14.5% · RS bench -18.8% · 1Y -27.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 17.3 + 7.3 + 0 = 43 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Niva Bupa Health Insurance Company LtdNIVABUPA | 42.7/100Mixed-negative evidence61% evidence | ASLEEP | 17.0/35 Income 27.9% · PAT -42.6% 52% evidence | 8.9/25 ROA — · ROE 3.5% · GNPA — 34% evidence | 3.8/20 P/BV 3.9× · P/BV÷ROE 1.13 70% evidence | 13.0/20 RS sector 7.4% · RS bench 2.4% · 1Y -5.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 8.9 + 3.8 + 13 = 42.7 · Decision use: Price leads the evidence: RS versus the benchmark is 2.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 6Religare Enterprises Ltdthis pageRELIGARE | 41.2/100Thin evidence · provisional55% evidence | TURNING | 15.4/35 Income 19% · PAT -80% 52% evidence | 8.8/25 ROA — · ROE 3.2% · GNPA — 34% evidence | 5.2/20 P/BV 2.94× · P/BV÷ROE 0.93 70% evidence | 11.8/20 RS sector -2.1% · RS bench 8% · 1Y 1.4%7 of 11 weeks ahead 70% evidence |
| Exact sum: 15.4 + 8.8 + 5.2 + 11.8 = 41.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7SBI Life Insurance Company LtdSBILIFE | 39.3/100Mixed-negative evidence76% evidence | BASING | 7.9/35 Income -1.3% · PAT 4.6% 86% evidence | 13.6/25 ROA 0.4% · ROE 13.7% · GNPA — 72% evidence | 5.3/20 P/BV 8.38× · P/BV÷ROE 0.61 70% evidence | 12.5/20 RS sector 4.4% · RS bench -10% · 1Y -6.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 7.9 + 13.6 + 5.3 + 12.5 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8HDFC Life Insurance Company LtdHDFCLIFE | 36.8/100Mixed-negative evidence76% evidence | BASING | 13.3/35 Income 4.3% · PAT 5.1% 86% evidence | 12.7/25 ROA 0.5% · ROE 11.3% · GNPA — 72% evidence | 6.3/20 P/BV 5.89× · P/BV÷ROE 0.52 70% evidence | 4.5/20 RS sector -12.5% · RS bench -18.4% · 1Y -30.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.3 + 12.7 + 6.3 + 4.5 = 36.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Religare Enterprises Ltd's share price today?
Religare Enterprises Ltd trades at ₹257, +1.4% over the past year. The company is valued at ₹8,853 Cr. The stock sits at 70% of its 52-week range of ₹208–₹278, +6.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 11 weeks in. — as of 11 September 2026.
What were Religare Enterprises Ltd's latest quarterly results?
Religare Enterprises Ltd reported total income of ₹2,353 Cr and a net loss of ₹47.0 Cr for the Jun 26 quarter. Income rose 26.4% and profit fell 687.5% year on year. Earnings per share were ₹−0.77. The net margin was −2.0%, 2.4 pp lower than a year earlier. — as of 11 September 2026.
What is Religare Enterprises Ltd's revenue?
Religare Enterprises Ltd reported revenue of ₹2,353 Cr in the Jun 26 quarter, +26.4% year on year. For the full FY26 fiscal year, revenue was ₹8,462 Cr (+14.4%). Over the last 10 years revenue compounded at 5.6% a year. — as of 11 September 2026.
What is Religare Enterprises Ltd's profit?
Religare Enterprises Ltd earned ₹−47.0 Cr of net profit in the Jun 26 quarter, −687.5% year on year. Full-year FY26 profit was ₹73.0 Cr. The net margin ran −2.0% in the latest quarter. — as of 11 September 2026.
What is Religare Enterprises Ltd's market cap?
Religare Enterprises Ltd's market capitalisation is ₹8,853 Cr at a share price of ₹257. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Religare Enterprises Ltd's P/BV ratio?
Religare Enterprises Ltd trades at a P/BV of 2.9×, at the 63rd percentile of its own 11-year range, against a long-run median of 1.5×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Religare Enterprises Ltd pay a dividend?
No — Religare Enterprises Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
Is Religare Enterprises Ltd overvalued?
On its own history, Religare Enterprises Ltd looks mid-range: its P/BV of 2.9× sits at the 63rd percentile of its 11-year range (long-run median 1.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Religare Enterprises Ltd growing?
Not right now — Religare Enterprises Ltd's latest numbers are shrinking: latest-quarter revenue +26.4% year on year, profit −687.5%, and the net margin −2.4 pp at −2.0%. The 10-year compound rates are 5.6% (revenue) and 1.8% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is Religare Enterprises Ltd performing?
Religare Enterprises Ltd is in a confirmed uptrend, 11 weeks in. Its latest quarter's income rose 26.4% and profit fell 687.5% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Religare Enterprises Ltd in?
Deteriorating — profit and EPS growth are shrinking (profit growth −89.1% latest against −40.2% at its 12-quarter best). The read comes from the last 12 quarters of growth (revenue growth +19.0% latest, profit growth −89.1% latest, eps growth −57.3% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Religare Enterprises Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 11 of stage 2), trading +6.1% versus its 200-day average and at 70% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Religare Enterprises Ltd beating the market?
Not lately — on a trailing-13-week view Religare Enterprises Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-09-04), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved −10% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.
Will Religare Enterprises Ltd's share price go up?
This page publishes no price forecast for Religare Enterprises Ltd. What it measures instead: the share price is ₹257, the price is in a confirmed uptrend 11 weeks in. Its P/BV of 2.9× sits at the 63rd percentile of its own 11-year range. — as of 11 September 2026.
Who owns Religare Enterprises Ltd?
Promoters hold 30.6% of Religare Enterprises Ltd, foreign institutions 9.6%, domestic institutions 9.3% and the public 50.5% (latest quarter). The biggest move on the register over the last two years: Promoters added 30.6 points over 8 quarters. — as of 11 September 2026.
Where is Religare Enterprises Ltd in its business cycle?
Religare Enterprises Ltd's FY26 net margin was 0.9%, against a 13-year band of −63.3%–67.7%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −2.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the Religare Enterprises Ltd story?
The sharpest disagreement: the price moved +1.4% in a year while annual EPS moved −31.6% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Religare Enterprises Ltd a stock worth studying right now?
This is not investment advice. The machine read: Religare Enterprises Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!